Below are the financial statements of Sun Pharmaceutical Industries, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of INR | 2025 | 2024 |
|---|---|---|
| Non-current assets | — | — |
| Property, plant and equipment | 100,359.4a | 101,923.2a |
| Capital work-in-progress | 12,343.4a | 11,077.3a |
| Goodwill (net) | 89,394.2a | 85,689.9a |
| Other intangible assets | 36,109.2a | 44,868.4a |
| Intangible assets under development | 54,096.2a | 42,461.5a |
| Financial assets | — | — |
| Investments | 46,977a | 64,412.3a |
| Loans | 27.9a | 8.5a |
| Other financial assets | 1,770.4a | 1,179.5a |
| Deferred tax assets (net) | 44,075.5a | 41,036.5a |
| Income tax assets (net) | 4,206.7a | 22,850.3a |
| Other non-current assets | 5,401.2a | 4,739.3a |
| Total non-current assets | 394,761.1a | 420,246.7a |
| Current assets | — | — |
| Inventories | 102,433.3a | 98,682.9a |
| Financial assets | — | — |
| Investments | 136,561a | 85,845.4a |
| Trade receivables | 130,461.1a | 112,493.7a |
| Cash and cash equivalents | 102,687.7a | 92,856.5a |
| Bank balances other than (iii) above | 10,628.5a | 12,350.3a |
| Loans | 483.8a | 650.2a |
| Other financial assets | 17,406.6a | 9,172a |
| Other current assets | 25,278.6a | 22,280.1a |
| Total current assets | 525,940.6a | 434,331.1a |
| Assets | — | — |
| Assets classified as held for sale | 304.1a | 418.7a |
| Total assets | 921,005.8a | 854,996.5a |
| Equity | — | — |
| Equity share capital | 2,399.3a | 2,399.3a |
| Other equity | 719,780.9a | 634,268.2a |
| Equity attributable to the equity shareholders of the parent company | 722,180.2a | 636,667.5a |
| Non-controlling interests | 2,679.3a | 34,591.9a |
| Total equity | 724,859.5a | 671,259.4a |
| Financial liabilities | — | — |
| Borrowings | 25.2a | 13.3a |
| Lease liabilities | 3,557.4a | 3,022.9a |
| Other financial liabilities | 106.8a | 0a |
| Non-current liabilities | — | — |
| Provisions | 4,650.4a | 4,138.9a |
| Deferred tax liabilities (net) | 1,924.4a | 1,718.6a |
| Other non-current liabilities | 3,852.4a | 4,999.4a |
| Non-current tax liabilities (net) | 87.6a | 0a |
| Total non-current liabilities | 14,204.2a | 13,893.1a |
| Financial liabilities | — | — |
| Borrowings | 18,671.1a | 28,443.6a |
| Lease liabilities | 1,368.2a | 1,256.9a |
| Trade payables | 61,843.4a | 56,533a |
| Other financial liabilities | 19,478.4a | 15,067a |
| Current liabilities | — | — |
| Other current liabilities | 11,697.9a | 10,844.6a |
| Provisions | 61,551.3a | 53,575.6a |
| Current tax liabilities (net) | 7,331.8a | 4,117a |
| Total current liabilities | 181,942.1a | 169,837.7a |
| Liabilities | — | — |
| Liabilities directly associated with assets classified as held for sale | 0a | 6.3a |
| Total liabilities | 196,146.3a | 183,737.1a |
| Total equity and liabilities | 921,005.8a | 854,996.5a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sun Pharmaceutical Industries’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.